Almost three years is a long time to wait for the public markets to open up to the developing digital health sector but when they do corporate venturing portfolio companies have been first through the flotation exit doors. This summer has seen four well-received initial public offerings (IPO) of digital healthcare companies, increasing the chances… Continue reading Editorial: Digital health comes of age in IPO surge
Category: Analysis
Editorial: ‘Bonkers’, ‘weirdness’ and ‘impossible’ IPOs
“WeWork’s Bonkers IPO,” according to Fortune’s daily newsletter, mirrored by sister title, CEO Daily’s “The Weirdness of WeWork’s IPO Filing” as it noted: “If a recession is coming, the WeWork IPO filing… will be a fitting capstone for the peak.” The Financial Times’s analysis, WeWork: You Pay, noted: “WeWork parent The We Company is about… Continue reading Editorial: ‘Bonkers’, ‘weirdness’ and ‘impossible’ IPOs
Analysis: Corporates reach Terminus at $283m
Several corporate venturers have backed IoT company Terminus Technologies in a $283m series C1 round. This nine-figure round comes to confirm an upward trend in valuations of such enterprises we have been observing for years.
Analysis: IPOs of corporate-backed businesses
Last year there was a peak in number of IPOs of corporate-backed emerging business, while the first half of 2019 hosted some much-awaited flotations like those of Uber, Lyft and Slack. We look at the broader picture for corporate-backed companies going public.
Analysis: Monitoring nine-figure corporate-backed rounds
Rounds above $100m tend to be raised by companies based in the US and China. Last year we saw a record number of corporate-backed rounds.
Analysis: First-time corporate investors
Since the beginning of 2018, a fifth of all corporate investors whose deals we track appear to be newcomers.
Analysis: Vungle’s $750m acquisition
Blackstone will purchase the advertising platform Vungle in a deal giving exits to corporates Alphabet and Verizon.
Analysis: Biontech gets a $325m series B round
Cancer treatment company Biontech raised $325m round backed by Fidelity. The company forms part of the hopeful oncology and cancer treatment subsector of life sciences which has seen much growth and in corporate backing in recent years.
More deals and fewer dollars in the second quarter
Analysis: Q2 2019
PitchBook seeks the golden mean of corporate venturing
The latest note by data provider PitchBook found that, in the context of growth in corporate venture capital, the most active CVC arms it examines have shown a strong historical performance and corporate-backed portfolio companies have reaped benefits in the form of higher exit chances and lower bankruptcy rates
Switzerland’s land of opportunity
Innovative region: Switzerland
The future for $100m rounds and the innovation economy
It has been a remarkable decade for innovation capital. More than $1 trillion of venture capital had been invested by the end of last year, according to data provider Pitchbook, driven by corporations engaging in more than half that total, according to GCV Analytics.
IT sector continues to nurture innovation
Sector Analysis: Information Technology
Slowdown in June
Monthly analysis: June 2019